Posted in | News | Iron Ore | Mining Business

Atlas Iron Receives Final Environmental Approvals for Mt Dove Project

Atlas Iron has announced that it has updated the progress on its targeted production rate of 12 mtpa by next year end.

The company announced that it has secured final environmental approvals for the Mt Dove mine and has obtained all essential agreements and approvals to start mining operations at the Mt Dove mine. Construction will begin in early July 2012 and the company has planned to commission by this year end.

Atlas is looking forward to commence production from the Mt Dove and increase its rate of production to 8 mtpa in North Pilbara during March 2013. The overall Atlas Pilbara blend will be improved by the grade contribution, wherein the life of mine at the Mt Dove project is comparatively short at around 15 months.

MACA has received the construction and operating contracts of the Mt Dove mine from Atlas in order to extend the current collaboration at the Pardoo mine.

The Abydos mine has secured interim approvals and the company has started the construction of temporary accommodation plants to prepare for mining operations during May 2012. Environmental approvals for expanding the Abydos mine are progressing well and the company anticipates receiving the final consent to excavate at Abydos during September 2012. Atlas is looking forward to offer the main construction and operating orders for the Abydos Mine during July 2012.

The company intends to begin production at Mt Webber in December 2013. The rate of production will begin at 2 Mtpa and increase to 6 Mtpa. The production rate of the company may expand to 12 Mtpa.

Source: http://www.atlasiron.com.au/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Atlas Iron Limited. (2019, February 18). Atlas Iron Receives Final Environmental Approvals for Mt Dove Project. AZoMining. Retrieved on May 25, 2024 from https://www.azomining.com/News.aspx?newsID=6724.

  • MLA

    Atlas Iron Limited. "Atlas Iron Receives Final Environmental Approvals for Mt Dove Project". AZoMining. 25 May 2024. <https://www.azomining.com/News.aspx?newsID=6724>.

  • Chicago

    Atlas Iron Limited. "Atlas Iron Receives Final Environmental Approvals for Mt Dove Project". AZoMining. https://www.azomining.com/News.aspx?newsID=6724. (accessed May 25, 2024).

  • Harvard

    Atlas Iron Limited. 2019. Atlas Iron Receives Final Environmental Approvals for Mt Dove Project. AZoMining, viewed 25 May 2024, https://www.azomining.com/News.aspx?newsID=6724.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.